← Back to directory

Atsushi Nakajima

Researcher Next ID · RN-035796

Researcher · Medicine

Tokyo Denki University

Tokyo, Japan

Accepting doctoral researchersFunding unknown
Works count
1,455
Citation count
37,600
H-index
91
i10-index
599

Research interests

Medicine
Liver Disease Diagnosis and Treatment
Liver Disease and Transplantation
Gastrointestinal motility and disorders
Liver Diseases and Immunity
Hepatocellular Carcinoma Treatment and Prognosis

Publications

  • Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease

    JAMA · 2024 · 10.1001/jama.2024.1447

  • Liver cancer in 2021: Global Burden of Disease study

    Journal of Hepatology · 2024 · 10.1016/j.jhep.2024.10.031

  • Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

    ˜The œLancet. Gastroenterology & hepatology · 2023 · 10.1016/s2468-1253(23)00141-3

  • Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

    Gut · 2021 · https://doi.org/10.1136/gutjnl-2021-324243

  • Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator‐activated receptor α modulator (SPPARMα), versus placebo in patients with non‐alcoholic fatty liver disease

    Alimentary Pharmacology & Therapeutics · 2021 · 10.1111/apt.16596

  • Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity

    Gut · 2018 · 10.1136/gutjnl-2018-316661

  • Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants

    Clinical Gastroenterology and Hepatology · 2018 · 10.1016/j.cgh.2018.05.059

  • Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

    Journal of Hepatology · 2018 · https://doi.org/10.1016/j.jhep.2018.05.036

  • Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial

    The Lancet Oncology · 2016 · https://doi.org/10.1016/s1470-2045(15)00565-3

  • Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

    Journal of Gastroenterology · 2015 · 10.1007/s00535-015-1050-7

  • Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography

    Gastroenterology · 2015 · https://doi.org/10.1053/j.gastro.2015.11.048

  • Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

    Hepatology Research · 2015 · 10.1111/hepr.12511

  • Protective mucosal immunity mediated by epithelial CD1d and IL-10

    Nature · 2014 · 10.1038/nature13150

  • Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan

    Human Genetics · 2013 · 10.1007/s00439-013-1294-3

  • Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease

    BMC Gastroenterology · 2012 · 10.1186/1471-230x-12-16

  • Hyperresponsivity to Low-Dose Endotoxin during Progression to Nonalcoholic Steatohepatitis Is Regulated by Leptin-Mediated Signaling

    Cell Metabolism · 2012 · 10.1016/j.cmet.2012.05.012

  • Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial

    Cancer Prevention Research · 2010 · 10.1158/1940-6207.capr-10-0186

  • Nonalcoholic Fatty Liver Disease: US-based Acoustic Radiation Force Impulse Elastography

    Radiology · 2010 · 10.1148/radiol.10091662

  • Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis # †

    Hepatology · 2009 · 10.1002/hep.23094

  • Variations in the FTO gene are associated with severe obesity in the Japanese

    Journal of Human Genetics · 2008 · https://doi.org/10.1007/s10038-008-0283-1

  • High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH

    Journal of Gastroenterology · 2007 · 10.1007/s00535-007-2060-x

  • Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD)

    Gut · 2007 · 10.1136/gut.2007.126417

  • Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD)

    Digestive and Liver Disease · 2007 · https://doi.org/10.1016/j.dld.2007.10.019

  • FOXP3+ Regulatory T Cells Affect the Development and Progression of Hepatocarcinogenesis

    Clinical Cancer Research · 2007 · https://doi.org/10.1158/1078-0432.ccr-06-2363

  • Endogenous PPARγ mediates anti-inflammatory activity in murine ischemia-reperfusion injury

    Gastroenterology · 2001 · 10.1053/gast.2001.21191

Current projects

    No projects listed.